Review



mdm2 inhibitor nutlin 3a  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    MedChemExpress mdm2 inhibitor nutlin 3a
    Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or <t>Nutlin-3a.</t> J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test
    Mdm2 Inhibitor Nutlin 3a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 94 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mdm2+inhibitor+nutlin+3a/Nutlin-3a/pmc12465477-57-18-33
    Average 96 stars, based on 94 article reviews
    mdm2 inhibitor nutlin 3a - by Bioz Stars, 2026-10
    96/100 stars

    Images

    1) Product Images from "RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs"

    Article Title: RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs

    Journal: European Journal of Medical Research

    doi: 10.1186/s40001-025-03116-y

    Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or Nutlin-3a. J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test
    Figure Legend Snippet: Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or Nutlin-3a. J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test

    Techniques Used: Biomarker Discovery, Transfection, Western Blot

    RHBDD1 Regulates the Cell Cycle through DNA-PKcs/p53 Signaling. A Cell cycle analysis of transfected NCI-H596 cells co-treated with STL127705 or Nutlin-3a for 48 h by flow cytometry. B Cell cycle distribution. C Viability of transfected NCI-H596 cells co-treated with STL127705 or Nutlin-3a for 48 h. Data are shown as mean ± SD. N = 3 for flow cytometry and N = 6 for CCK-8 assays. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test
    Figure Legend Snippet: RHBDD1 Regulates the Cell Cycle through DNA-PKcs/p53 Signaling. A Cell cycle analysis of transfected NCI-H596 cells co-treated with STL127705 or Nutlin-3a for 48 h by flow cytometry. B Cell cycle distribution. C Viability of transfected NCI-H596 cells co-treated with STL127705 or Nutlin-3a for 48 h. Data are shown as mean ± SD. N = 3 for flow cytometry and N = 6 for CCK-8 assays. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test

    Techniques Used: Cell Cycle Assay, Transfection, Flow Cytometry, CCK-8 Assay

    RHBDD1 Regulates DNA-PKcs and p53 Levels in an ERAD-Dependent Manner. A ERAD marker analysis in sh-RHBDD1- or pcDNA-RHBDD1-transfected cells treated with STL127705 or Nutlin-3a, assessed by western blotting. B Relative protein levels in sh-RHBDD1 transfected cells. C Apoptosis induced by cisplatin in pcDNA-RHBDD1-transfected A549 and NCI-H596 cells. Data are shown as mean ± SD. N = 3 for western blot analysis. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test
    Figure Legend Snippet: RHBDD1 Regulates DNA-PKcs and p53 Levels in an ERAD-Dependent Manner. A ERAD marker analysis in sh-RHBDD1- or pcDNA-RHBDD1-transfected cells treated with STL127705 or Nutlin-3a, assessed by western blotting. B Relative protein levels in sh-RHBDD1 transfected cells. C Apoptosis induced by cisplatin in pcDNA-RHBDD1-transfected A549 and NCI-H596 cells. Data are shown as mean ± SD. N = 3 for western blot analysis. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test

    Techniques Used: Marker, Transfection, Western Blot

    Related Articles

    Biomarker Discovery:

    Article Title: RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs
    Article Snippet: Cells at 70% confluence were transfected with the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′.the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′. ... The DNA-PKcs inhibitor STL127705 (3.5 μM, HY-122727, MCE, Shanghai, China), USP7 inhibitor HBX 41108 (424 nM, HY-101666, MCE), MDM2 inhibitor Nutlin-3a (90 nM, N129972, Aladdin, Shanghai, China), proteasome inhibitor PYR-41 (10 μM, HY-13296, MCE), and cisplatin (13 μM, HY-17394, MCE) were dissolved in DMSO and added to the medium for 48-h treatments.

    Transfection:

    Article Title: RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs
    Article Snippet: Cells at 70% confluence were transfected with the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′.the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′. ... The DNA-PKcs inhibitor STL127705 (3.5 μM, HY-122727, MCE, Shanghai, China), USP7 inhibitor HBX 41108 (424 nM, HY-101666, MCE), MDM2 inhibitor Nutlin-3a (90 nM, N129972, Aladdin, Shanghai, China), proteasome inhibitor PYR-41 (10 μM, HY-13296, MCE), and cisplatin (13 μM, HY-17394, MCE) were dissolved in DMSO and added to the medium for 48-h treatments.

    Western Blot:

    Article Title: RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs
    Article Snippet: Cells at 70% confluence were transfected with the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′.the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′. ... The DNA-PKcs inhibitor STL127705 (3.5 μM, HY-122727, MCE, Shanghai, China), USP7 inhibitor HBX 41108 (424 nM, HY-101666, MCE), MDM2 inhibitor Nutlin-3a (90 nM, N129972, Aladdin, Shanghai, China), proteasome inhibitor PYR-41 (10 μM, HY-13296, MCE), and cisplatin (13 μM, HY-17394, MCE) were dissolved in DMSO and added to the medium for 48-h treatments.

    Cell Cycle Assay:

    Article Title: RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs
    Article Snippet: Cells at 70% confluence were transfected with the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′.the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′. ... The DNA-PKcs inhibitor STL127705 (3.5 μM, HY-122727, MCE, Shanghai, China), USP7 inhibitor HBX 41108 (424 nM, HY-101666, MCE), MDM2 inhibitor Nutlin-3a (90 nM, N129972, Aladdin, Shanghai, China), proteasome inhibitor PYR-41 (10 μM, HY-13296, MCE), and cisplatin (13 μM, HY-17394, MCE) were dissolved in DMSO and added to the medium for 48-h treatments.

    Flow Cytometry:

    Article Title: RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs
    Article Snippet: Cells at 70% confluence were transfected with the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′.the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′. ... The DNA-PKcs inhibitor STL127705 (3.5 μM, HY-122727, MCE, Shanghai, China), USP7 inhibitor HBX 41108 (424 nM, HY-101666, MCE), MDM2 inhibitor Nutlin-3a (90 nM, N129972, Aladdin, Shanghai, China), proteasome inhibitor PYR-41 (10 μM, HY-13296, MCE), and cisplatin (13 μM, HY-17394, MCE) were dissolved in DMSO and added to the medium for 48-h treatments.

    CCK-8 Assay:

    Article Title: RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs
    Article Snippet: Cells at 70% confluence were transfected with the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′.the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′. ... The DNA-PKcs inhibitor STL127705 (3.5 μM, HY-122727, MCE, Shanghai, China), USP7 inhibitor HBX 41108 (424 nM, HY-101666, MCE), MDM2 inhibitor Nutlin-3a (90 nM, N129972, Aladdin, Shanghai, China), proteasome inhibitor PYR-41 (10 μM, HY-13296, MCE), and cisplatin (13 μM, HY-17394, MCE) were dissolved in DMSO and added to the medium for 48-h treatments.

    Marker:

    Article Title: RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs
    Article Snippet: Cells at 70% confluence were transfected with the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′.the vectors in Opti-MEM TM medium (31985070, Invitrogen, USA) using PEI reagent (40815ES03, Yeason, Shanghai, China) for 48 h. After transfection, cells were treated with other reagents and collected within 72 h. The shRNAs used were: shRNA 1: 5′-GATCGCCTATGTTATCACCGCATTTCTCGAGAAATGCGGTGATAACATAGGCTTTTTG-3′; shRNA 2: 5′-GATCGCTGGGATTCTTGTTGGACTATCGAGTAGTCCAACAAGAATCCCAGCTTTTTG-3′. ... The DNA-PKcs inhibitor STL127705 (3.5 μM, HY-122727, MCE, Shanghai, China), USP7 inhibitor HBX 41108 (424 nM, HY-101666, MCE), MDM2 inhibitor Nutlin-3a (90 nM, N129972, Aladdin, Shanghai, China), proteasome inhibitor PYR-41 (10 μM, HY-13296, MCE), and cisplatin (13 μM, HY-17394, MCE) were dissolved in DMSO and added to the medium for 48-h treatments.



    Similar Products

    96
    MedChemExpress mdm2 inhibitor nutlin 3a
    Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or <t>Nutlin-3a.</t> J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test
    Mdm2 Inhibitor Nutlin 3a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mdm2+inhibitor+nutlin+3a/Nutlin-3a/pmc12465477-57-18-33
    Average 96 stars, based on 1 article reviews
    mdm2 inhibitor nutlin 3a - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    90
    Cayman Chemical mdm2 inhibitor nutlin-3a
    Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or <t>Nutlin-3a.</t> J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test
    Mdm2 Inhibitor Nutlin 3a, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mdm2+inhibitor+nutlin+3a/mdm2+inhibitor+nutlin/bio_rxiv__2025__06__05__656583-50-3-6
    Average 90 stars, based on 1 article reviews
    mdm2 inhibitor nutlin-3a - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    94
    Selleck Chemicals mdm2 inhibitor nutlin 3a
    Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or <t>Nutlin-3a.</t> J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test
    Mdm2 Inhibitor Nutlin 3a, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mdm2+inhibitor+nutlin+3a/Nutlin-3a/pm40285353-215-12-17
    Average 94 stars, based on 1 article reviews
    mdm2 inhibitor nutlin 3a - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    90
    Millipore mdm2 inhibitor nutlin-3a sml0580
    Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or <t>Nutlin-3a.</t> J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test
    Mdm2 Inhibitor Nutlin 3a Sml0580, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mdm2+inhibitor+nutlin+3a/mdm2+antibody/pm39736453-61-0-7
    Average 90 stars, based on 1 article reviews
    mdm2 inhibitor nutlin-3a sml0580 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    TranScrip Partners mdm2 inhibitor nutlin-3a
    Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or <t>Nutlin-3a.</t> J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test
    Mdm2 Inhibitor Nutlin 3a, supplied by TranScrip Partners, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mdm2+inhibitor+nutlin+3a/mdm2+inhibitor+nutlin+3a/pm38368146-437-11-20
    Average 90 stars, based on 1 article reviews
    mdm2 inhibitor nutlin-3a - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Millipore mdm2 inhibitor nutlin-3a (sml0580)
    Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or <t>Nutlin-3a.</t> J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test
    Mdm2 Inhibitor Nutlin 3a (Sml0580), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mdm2+inhibitor+nutlin+3a/mdm2+antibody/ppr0599301-62-0-7
    Average 90 stars, based on 1 article reviews
    mdm2 inhibitor nutlin-3a (sml0580) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    94
    Tocris mdm2 inhibitor nutlin3a
    Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or <t>Nutlin-3a.</t> J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test
    Mdm2 Inhibitor Nutlin3a, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mdm2+inhibitor+nutlin+3a/Nutlin+3a/pm36322626-179-0-3
    Average 94 stars, based on 1 article reviews
    mdm2 inhibitor nutlin3a - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Selleck Chemicals mdm2 15 inhibitor nutlin 3a
    Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or <t>Nutlin-3a.</t> J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test
    Mdm2 15 Inhibitor Nutlin 3a, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mdm2+inhibitor+nutlin+3a/Nutlin-3a/pmc09198927__advancesADV2021005859___suppl1-17-26-31
    Average 94 stars, based on 1 article reviews
    mdm2 15 inhibitor nutlin 3a - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or Nutlin-3a. J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test

    Journal: European Journal of Medical Research

    Article Title: RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs

    doi: 10.1186/s40001-025-03116-y

    Figure Lengend Snippet: Effect of RHBDD1 on DNA-PKcs/p53 Signaling. A Validation of transfection in A549 cells by qPCR. B Validation of transfection in A549 cells by western blotting. C Levels of RHBDD1, DNA-PKcs, and p53 proteins in sh-RHBDD1-transfected A549 cells treated with the DNA-PKcs inhibitor STL127705. D Protein levels analyzed using ImageJ. E Validation of transfection in NCI-H596 cells by qPCR. F Validation of transfection in in NCI-H596 cells by western blotting. G Levels of RHBDD1, DNA-PKcs and p53 in sh-RHBDD1 transfected NCI-H596 cells treated with STL127705. H The protein levels were analyzed by ImageJ. I Levels of RHBDD1, DNA-PKcs, and p53 in pcDNA-RHBDD1 transfected NCI-H596 cells co-treated with HBX41108 or Nutlin-3a. J Protein levels were analyzed using ImageJ. Data are shown as mean ± SD. N = 3 for all tests. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test

    Article Snippet: The DNA-PKcs inhibitor STL127705 (3.5 μM, HY-122727, MCE, Shanghai, China), USP7 inhibitor HBX 41108 (424 nM, HY-101666, MCE), MDM2 inhibitor Nutlin-3a (90 nM, N129972, Aladdin, Shanghai, China), proteasome inhibitor PYR-41 (10 μM, HY-13296, MCE), and cisplatin (13 μM, HY-17394, MCE) were dissolved in DMSO and added to the medium for 48-h treatments.

    Techniques: Biomarker Discovery, Transfection, Western Blot

    RHBDD1 Regulates the Cell Cycle through DNA-PKcs/p53 Signaling. A Cell cycle analysis of transfected NCI-H596 cells co-treated with STL127705 or Nutlin-3a for 48 h by flow cytometry. B Cell cycle distribution. C Viability of transfected NCI-H596 cells co-treated with STL127705 or Nutlin-3a for 48 h. Data are shown as mean ± SD. N = 3 for flow cytometry and N = 6 for CCK-8 assays. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test

    Journal: European Journal of Medical Research

    Article Title: RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs

    doi: 10.1186/s40001-025-03116-y

    Figure Lengend Snippet: RHBDD1 Regulates the Cell Cycle through DNA-PKcs/p53 Signaling. A Cell cycle analysis of transfected NCI-H596 cells co-treated with STL127705 or Nutlin-3a for 48 h by flow cytometry. B Cell cycle distribution. C Viability of transfected NCI-H596 cells co-treated with STL127705 or Nutlin-3a for 48 h. Data are shown as mean ± SD. N = 3 for flow cytometry and N = 6 for CCK-8 assays. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test

    Article Snippet: The DNA-PKcs inhibitor STL127705 (3.5 μM, HY-122727, MCE, Shanghai, China), USP7 inhibitor HBX 41108 (424 nM, HY-101666, MCE), MDM2 inhibitor Nutlin-3a (90 nM, N129972, Aladdin, Shanghai, China), proteasome inhibitor PYR-41 (10 μM, HY-13296, MCE), and cisplatin (13 μM, HY-17394, MCE) were dissolved in DMSO and added to the medium for 48-h treatments.

    Techniques: Cell Cycle Assay, Transfection, Flow Cytometry, CCK-8 Assay

    RHBDD1 Regulates DNA-PKcs and p53 Levels in an ERAD-Dependent Manner. A ERAD marker analysis in sh-RHBDD1- or pcDNA-RHBDD1-transfected cells treated with STL127705 or Nutlin-3a, assessed by western blotting. B Relative protein levels in sh-RHBDD1 transfected cells. C Apoptosis induced by cisplatin in pcDNA-RHBDD1-transfected A549 and NCI-H596 cells. Data are shown as mean ± SD. N = 3 for western blot analysis. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test

    Journal: European Journal of Medical Research

    Article Title: RHBDD1 induces cell cycle arrest in TP53-mutant NSCLC cells by promoting endoplasmic reticulum-associated degradation of p53 and DNA-PKcs

    doi: 10.1186/s40001-025-03116-y

    Figure Lengend Snippet: RHBDD1 Regulates DNA-PKcs and p53 Levels in an ERAD-Dependent Manner. A ERAD marker analysis in sh-RHBDD1- or pcDNA-RHBDD1-transfected cells treated with STL127705 or Nutlin-3a, assessed by western blotting. B Relative protein levels in sh-RHBDD1 transfected cells. C Apoptosis induced by cisplatin in pcDNA-RHBDD1-transfected A549 and NCI-H596 cells. Data are shown as mean ± SD. N = 3 for western blot analysis. *p < 0.05, **p < 0.01 by one-way ANOVA with Tukey’s multiple comparisons test

    Article Snippet: The DNA-PKcs inhibitor STL127705 (3.5 μM, HY-122727, MCE, Shanghai, China), USP7 inhibitor HBX 41108 (424 nM, HY-101666, MCE), MDM2 inhibitor Nutlin-3a (90 nM, N129972, Aladdin, Shanghai, China), proteasome inhibitor PYR-41 (10 μM, HY-13296, MCE), and cisplatin (13 μM, HY-17394, MCE) were dissolved in DMSO and added to the medium for 48-h treatments.

    Techniques: Marker, Transfection, Western Blot